Table 7.
Selected cardiovascular adverse events during drug administration
|
Adverse events |
High BNP group |
Extra-high BNP group |
||||
|---|---|---|---|---|---|---|
| Dobutamine (n = 30) | rhBNP (n = 28) | P value | Dobutamine (n = 23) | rhBNP (n = 24) | P value | |
| Symptomatic hypotension |
0 |
0 |
1.000 |
0 |
1 |
1.000 |
| Asymptomatic hypotension |
0 |
2 |
0.229 |
0 |
3 |
0.234 |
| Sustained VT |
0 |
0 |
1.000 |
0 |
0 |
1.000 |
| Nonsustained VT |
2 |
0 |
0.492 |
2 |
1 |
0.609 |
| VF |
0 |
0 |
1.000 |
0 |
0 |
1.000 |
| Sudden death |
0 |
0 |
1.000 |
0 |
0 |
1.000 |
| Cardiac arrest | 0 | 0 | 1.000 | 0 | 0 | 1.000 |
Abbrevations: VF ventricular fibrillation, VT ventricular tachycardia, Other abbreviations are same as in Table 2. Fisher exact text was used.